2026 Annual Lingeman Weisberger Lectureship

Friday, November 6, 2026, 12:00 PM - 3:30 PM, Hine Hall, Kelly Room 132, Indianapolis, IN


The lectureship is intended to provide otolaryngologists–head and neck surgeons and the general medical community with information on a variety of otolaryngology-related topics. 2026 topics will focus on public health challenges, leadership development, resilience, and reconstructive innovation/patient quality of life.

1. Analyze the impact of social, economic, and healthcare system challenges on patient outcomes, provider well-being, and healthcare delivery.
2. Identify and apply strategies to improve resilience, adaptability, and equitable care delivery in rapidly evolving clinical environments.
3. Describe leadership principles that foster trust, effective communication, collaboration, and professional growth within healthcare teams.
4. Develop actionable approaches to enhance leadership effectiveness through self-awareness, coaching, curiosity, and values-based decision-making
5. Evaluate contemporary advances in nasal reconstruction and their role in improving functional outcomes, appearance, and patient quality of life
6. Integrate evidence-based, patient-centered, and interdisciplinary approaches into clinical practice to improve healthcare team performance and patient outcomes.

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or [email protected]. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.

AMA PRA Category 1 Credits™ (2.50 hours), ABS CC (2.50 hours), Non-Physician Attendance (2.50 hours)

Indiana University School of Medicine (IUSM) policy ensures that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all financial relationships with ineligible companies so that IUSM may identify relevant financial relationships and mitigate any relevant financial relationships prior to the activity. All educational programs sponsored by Indiana University School of Medicine must demonstrate balance, independence, objectivity, and scientific rigor.

*Indiana University School of Medicine (IUSM) and ACCME defines an ineligible company as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

To view any relevant financial relationships with ineligible companies for anyone who was in control of the content of this activity, please click the names below.  All relevant financial relationships have been mitigated in accordance with ACCME and the IUSM Conflict of Interest Policy.

Mitigation of Relevant Financial Relationships

Indiana University School of Medicine, Office of Continuing Education in Healthcare Professions adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Friday, November 6, 2026